138 related articles for article (PubMed ID: 38704758)
1. Complementary information concerning the suspected interindividual transmission of GW1516, a substance prohibited in sport, through intimate contact: a case report.
Breuer J; Garzinsky AM; Thomas A; Nieschlag E; Kliesch S; Fedoruk M; Geyer H; Thevis M
Forensic Toxicol; 2024 May; ():. PubMed ID: 38704758
[TBL] [Abstract][Full Text] [Related]
2. Probing for the presence of semenogelin in human urine by immunological and chromatographic-mass spectrometric methods in the context of sports drug testing.
Breuer J; Thomas A; Geyer H; Thevis M
Anal Sci Adv; 2022 Feb; 3(1-2):21-28. PubMed ID: 38716057
[TBL] [Abstract][Full Text] [Related]
3. Characterization of two major urinary metabolites of the PPARdelta-agonist GW1516 and implementation of the drug in routine doping controls.
Thevis M; Möller I; Thomas A; Beuck S; Rodchenkov G; Bornatsch W; Geyer H; Schänzer W
Anal Bioanal Chem; 2010 Apr; 396(7):2479-91. PubMed ID: 19946680
[TBL] [Abstract][Full Text] [Related]
4. Metabolic study of GW1516 in equine urine using liquid chromatography/electrospray ionization Q-Exactive high-resolution mass spectrometry for doping control.
Ishii H; Shibuya M; Leung GN; Yamashita S; Yamada M; Kushiro A; Kasashima Y; Okada J; Kawasaki K; Kijima-Suda I
Rapid Commun Mass Spectrom; 2021 Mar; 35(5):e9028. PubMed ID: 33319421
[TBL] [Abstract][Full Text] [Related]
5. Detection of the diuretic hydrochlorothiazide in a doping control urine sample as the result of a non-steroidal anti-inflammatory drug (NSAID) tablet contamination.
Helmlin HJ; Mürner A; Steiner S; Kamber M; Weber C; Geyer H; Guddat S; Schänzer W; Thevis M
Forensic Sci Int; 2016 Oct; 267():166-172. PubMed ID: 27611956
[TBL] [Abstract][Full Text] [Related]
6. Reply to the paper of Breuer et al.: complementary information concerning the suspected interindividual transmission of GW1516, a substance prohibited in sport, through intimate contact-a case report.
Kintz P
Forensic Toxicol; 2024 Jun; ():. PubMed ID: 38935295
[No Abstract] [Full Text] [Related]
7. Detection of PPARδ agonists GW1516 and GW0742 and their metabolites in human urine.
Sobolevsky T; Dikunets M; Sukhanova I; Virus E; Rodchenkov G
Drug Test Anal; 2012 Oct; 4(10):754-60. PubMed ID: 22977012
[TBL] [Abstract][Full Text] [Related]
8. Mass spectrometry in sports drug testing-Analytical approaches and the athletes' exposome.
Thevis M; Görgens C; Guddat S; Thomas A; Geyer H
Scand J Med Sci Sports; 2024 Jan; 34(1):e14228. PubMed ID: 36539355
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, mass spectrometric characterization, and analysis of the PPARδ agonist GW1516 and its major human metabolites: targets in sports drug testing.
Thevis M; Möller I; Beuck S; Schänzer W
Methods Mol Biol; 2013; 952():301-12. PubMed ID: 23100242
[TBL] [Abstract][Full Text] [Related]
10. Detection and longitudinal distribution of GW1516 and its metabolites in equine hair for doping control using liquid chromatography/high-resolution mass spectrometry.
Ishii H; Shibuya M; Leung GN; Nozawa S; Yamashita S; Yamada M; Kushiro A; Kasashima Y; Okada J; Kawasaki K; Kijima-Suda I
Rapid Commun Mass Spectrom; 2021 Apr; 35(8):e9050. PubMed ID: 33470485
[TBL] [Abstract][Full Text] [Related]
11. Investigations into the concentration and metabolite profiles of stanozolol and LGD-4033 in blood plasma and seminal fluid using liquid chromatography high-resolution mass spectrometry.
Breuer J; Thomas A; Delahaut P; Schänzer W; Geyer H; Thevis M
Anal Bioanal Chem; 2023 Feb; 415(4):669-681. PubMed ID: 36441233
[TBL] [Abstract][Full Text] [Related]
12. Doping control analysis of GW1516 in equine plasma using liquid chromatography/electrospray ionization Q-Exactive high-resolution mass spectrometry.
Ishii H; Leung GN; Yamashita S; Yamada M; Kushiro A; Kasashima Y; Okada J; Kawasaki K; Kijima-Suda I
Rapid Commun Mass Spectrom; 2020 Dec; 34(23):e8920. PubMed ID: 32776613
[TBL] [Abstract][Full Text] [Related]
13. Emerging drugs affecting skeletal muscle function and mitochondrial biogenesis - Potential implications for sports drug testing programs.
Thevis M; Schänzer W
Rapid Commun Mass Spectrom; 2016 Mar; 30(5):635-51. PubMed ID: 26842585
[TBL] [Abstract][Full Text] [Related]
14. Body fluid contamination in the context of an adverse analytical finding in doping: About a case involving ostarine.
Alvarez JC; Etting I; Larabi IA
Clin Chim Acta; 2024 Apr; 557():117871. PubMed ID: 38467244
[TBL] [Abstract][Full Text] [Related]
15. The forensic response after an adverse analytical finding (doping) involving a selective androgen receptor modulator (SARM) in human athlete.
Kintz P
J Pharm Biomed Anal; 2022 Jan; 207():114433. PubMed ID: 34715583
[TBL] [Abstract][Full Text] [Related]
16. Preliminary data on the potential for unintentional antidoping rule violations by permitted cannabidiol (CBD) use.
Mareck U; Fusshöller G; Geyer H; Huestis MA; Scheiff AB; Thevis M
Drug Test Anal; 2021 Mar; 13(3):539-549. PubMed ID: 33125823
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome Proliferator-Activated Receptor Delta Agonist (PPAR- δ) and Selective Androgen Receptor Modulator (SARM) Abuse: Clinical, Analytical and Biological Data in a Case Involving a Poisonous Combination of GW1516 (Cardarine) and MK2866 (Ostarine).
Kintz P; Gheddar L; Paradis C; Chinellato M; Ameline A; Raul JS; Oliva-Labadie M
Toxics; 2021 Oct; 9(10):. PubMed ID: 34678947
[TBL] [Abstract][Full Text] [Related]
18. Urine analysis concerning xenon for doping control purposes.
Thevis M; Piper T; Geyer H; Schaefer MS; Schneemann J; Kienbaum P; Schänzer W
Rapid Commun Mass Spectrom; 2015 Jan; 29(1):61-6. PubMed ID: 25462364
[TBL] [Abstract][Full Text] [Related]
19. Expanding analytical possibilities concerning the detection of stanozolol misuse by means of high resolution/high accuracy mass spectrometric detection of stanozolol glucuronides in human sports drug testing.
Schänzer W; Guddat S; Thomas A; Opfermann G; Geyer H; Thevis M
Drug Test Anal; 2013; 5(11-12):810-8. PubMed ID: 23873860
[TBL] [Abstract][Full Text] [Related]
20. Multiple incidence of the prescription diuretic hydrochlorothiazide in compounded nutritional supplements.
Favretto D; Visentin S; Scrivano S; Roselli E; Mattiazzi F; Pertile R; Vogliardi S; Tucci M; Montisci M
Drug Test Anal; 2019 Mar; 11(3):512-522. PubMed ID: 30194914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
